Michigan Center First to Administer Controversial New Alzheimer's Drug
[unable to retrieve full-text content]
The first dose of the breakthrough, yet controversial, drug to treat Alzheimer's disease took place Wednesday morning marking a pivotal turn in the fight against the disease. The Food and Drug Administration (FDA) approved Aduhelm, which is manufactured by Biogen, on June 7...
Advertising by Adpathway




